369
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Changes in Medical Cannabis Patient Status before and after Cannabis Legalization in California: Associations with Cannabis and Other Drug Use

, DrPH, , DrPHORCID Icon, , PhD, , MPH & , PhD
Pages 129-139 | Received 10 Aug 2020, Accepted 18 Feb 2021, Published online: 27 May 2021
 

ABSTRACT

It is unknown how patterns of cannabis and other drug use changed among young adult cannabis users as they became, exited or stayed medical cannabis patients (MCPs) after California legalized cannabis for adult use in 2016. A cohort of 18–26 year-old cannabis users was recruited in Los Angeles in 2014–15 (64.8% male; 44.1% Hispanic/Latinx). Based on wave 1 (pre-legalization) and wave 4 (post-legalization) MCP status, four transition groups emerged: MCP, Into MCP, Out of MCP and NPU (non-patient user). Relationships between self-reported medical cannabis use, transition group membership, and cannabis/other drug use outcomes were examined. Changes in cannabis practices were consistent with changes in MCP status. Cannabis days, concentrate use, self-reported medical cannabis use and driving under influence of cannabis were highest among MCP, increased for Into MCP, and decreased for Out of MCP in wave 4. A majority of drug use outcomes decreased significantly by wave 4. Self-reported medical cannabis use was associated with more frequent cannabis use but less problematic cannabis and other drug use. Future studies should continue to monitor the impact of policies that legalize cannabis for medical or recreational use, and medical motivations for cannabis use on young adults’ cannabis and other drug use.

Acknowledgments

The authors would like to acknowledge the project’s Community Advisory Board and the following individuals who supported the development of this manuscript: Miles McNeely, Megan Treese, Ali Johnson, Chaka Dodson, Maral Shahinian, Avat Kioumarsi, Salini Mohanti, Megan Reed and Alexander Kecojevic.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This research study was funded by the National Institute on Drug Abuse under Grant R01-DA034067.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.